Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fisetin and Exercise to Prevent Frailty in Breast Cancer Survivors
NCT06113016Phase 2Recruiting
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jul 2024
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fisetin in frailty syndrome, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Jul 2024; status: recruiting.
02
Drugs
fisetin
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT06113016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06113016.